Showing results (1701-1710 of 1,946) with videos related to

Sort By:
Pageof 195
Quantitative Imaging in Medicine and Surgery|January 10, 2014
Ternary hybrid nanocomposites for gene delivery and magnetic resonance imaging of hepatocellular carcinoma cellsKen Cham-Fai Leung, Chi-Hin Wong, Xiao-Ming Zhu, et al.
Plos One|July 5, 2024
Association of poverty-income ratio with cardiovascular disease and mortality in cancer survivors in the United StatesVidhushei Yogeswaran, Youngdeok Kim, R Lee Franco, et al.
International Journal of Cancer|December 4, 2009
Fluid intake and the risk of bladder cancer: results from the South and East China case-control study on bladder cancerMarjolein Hemelt, Zhiquan Hu, Zhaohui Zhong, et al.
Reproductive Biomedicine Online|March 3, 2012
Spatial and temporal distribution of Oct-4 and acetylated H4K5 in rabbit embryosChien-Hong Chen, Wei-Fang Chang, Chia-Chia Liu, et al.
Methods (San Diego, Calif.)|July 2, 2013
Nanoparticle-DNA-polymer composites for hepatocellular carcinoma cell labeling, sensing, and magnetic resonance imagingKen Cham-Fai Leung, Siu-Fung Lee, Chi-Hin Wong, et al.
Bioorganic & Medicinal Chemistry Letters|June 27, 2001
Potent nonpeptide GnRH receptor antagonists derived from substituted indole-5-carboxamides and -acetamides bearing a pyridine side-chain terminusW T Ashton, R M Sisco, Y T Yang, et al.
Clinical Epigenetics|August 12, 2025
Detection of genome-wide methylation changes in bladder cancer by long-read sequencing of urinary DNAAnshita Goel, Benjamin J Tura, Joanne D Stockton, et al.
BMC Cancer|May 28, 2026
Eosinophil counts as a prognostic marker in glioblastoma: a retrospective cohort studyEric Giannaris, Geoffrey Sedor, Catherine S Spina, et al.
European Journal of Physical and Rehabilitation Medicine|August 26, 2025
Psychometric properties of the Chinese version of 21-item Fall Risk Index for community-dwelling older adults with strokePeiming Chen, Shamay S Ng, K Cheng, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 22, 2021
Oncogenic KRAS engages an RSK1/NF1 pathway to inhibit wild-type RAS signaling in pancreatic cancerDerek K Cheng, Tobiloba E Oni, Jennifer S Thalappillil, et al.
Pageof 195